Aurobindo Pharma ties up with BIRAC to develop Covid-19 vaccine | Latest News India - Hindustan Times
close_game
close_game

Aurobindo Pharma ties up with BIRAC to develop Covid-19 vaccine

Press Trust of India | ByPress Trust of India | Posted by Meenakshi Ray
Sep 15, 2020 05:29 PM IST

Aurobindo Pharma said it is developing a vaccine for COVID-19 through its wholly-owned US subsidiary, Auro Vaccines. The vaccine candidate is based on a proprietary vaccine delivery platform of the company.

Aurobindo Pharma on Tuesday announced collaboration with the Biotechnology Industry Research Assistance Council (BIRAC), set up by the Department of Biotechnology for the development of COVID-19 vaccine.

A health worker holds blood samples collected for coronavirus sero-survey in New Delhi in this file photo.(Sanchit Khanna/HT PHOTO)
A health worker holds blood samples collected for coronavirus sero-survey in New Delhi in this file photo.(Sanchit Khanna/HT PHOTO)

BIRAC has facilitated the establishment of ‘the r-VSV vaccine’ manufacturing platform for the first time in India by supporting Aurobindo Pharma’s COVID-19 vaccine development, the company said in a regulatory filing.

Hindustan Times - your fastest source for breaking news! Read now.

Aurobindo Pharma said it is developing a vaccine for COVID-19 through its wholly-owned US subsidiary, Auro Vaccines. The vaccine candidate is based on a proprietary vaccine delivery platform of the company.

“Aurobindo is in the process of setting up a state-of-art manufacturing facility for viral vaccines which will be used to produce the COVID-19 vaccine and other viral vaccines. The plant will comply with global standards. The company’s COVID-19 vaccine development is going as per plan,” the filing added.

Commenting on the collaboration, Aurobindo Pharma Managing Director N Govindarajan said, ”It is a matter of immense pride that BIRAC has placed its trust on our vaccine capabilities. The senior leadership of Aurobindo and Auro Vaccines has extensive experience in development, production and commercialization of several vaccines.” Department of Biotechnology Secretary and BIRAC Chairperson Renu Swarup said the partnership with Aurobindo is to serve the country’s need for a vaccine to fight this pandemic.

“The government is focussed on creating an ecosystem that nurtures and encourages new product innovation to address the most relevant issues to our society,” Swarup added.

Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the pharma firms in India working on the coronavirus vaccine.

Unveiling 'Elections 2024: The Big Picture', a fresh segment in HT's talk show 'The Interview with Kumkum Chadha', where leaders across the political spectrum discuss the upcoming general elections. Watch now!

Get Current Updates on India News, PM Narendra Modi in Kerala LIVE , Electoral Bonds Data Live along with Latest News and Top Headlines from India and around the world.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Friday, March 15, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On